DK165692C - Phenylbutenderivater, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat indeholdende disse, samt anvendelse af disse til fremstilling af et medikament nyttigt til inhibering af gaba-optagelse i mennesker - Google Patents

Phenylbutenderivater, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat indeholdende disse, samt anvendelse af disse til fremstilling af et medikament nyttigt til inhibering af gaba-optagelse i mennesker

Info

Publication number
DK165692C
DK165692C DK003887A DK3887A DK165692C DK 165692 C DK165692 C DK 165692C DK 003887 A DK003887 A DK 003887A DK 3887 A DK3887 A DK 3887A DK 165692 C DK165692 C DK 165692C
Authority
DK
Denmark
Prior art keywords
phenylbuten
admission
procedures
derivatives
prepare
Prior art date
Application number
DK003887A
Other languages
Danish (da)
English (en)
Other versions
DK165692B (da
DK3887D0 (no
DK3887A (no
Inventor
Ursula Sonnewald
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK5186A external-priority patent/DK5186D0/da
Priority claimed from DK95686A external-priority patent/DK95686D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of DK3887D0 publication Critical patent/DK3887D0/da
Publication of DK3887A publication Critical patent/DK3887A/da
Publication of DK165692B publication Critical patent/DK165692B/da
Application granted granted Critical
Publication of DK165692C publication Critical patent/DK165692C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK003887A 1986-01-07 1987-01-06 Phenylbutenderivater, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat indeholdende disse, samt anvendelse af disse til fremstilling af et medikament nyttigt til inhibering af gaba-optagelse i mennesker DK165692C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK5186 1986-01-07
DK5186A DK5186D0 (da) 1986-01-07 1986-01-07 Aminosyrer
DK95686A DK95686D0 (no) 1986-03-03 1986-03-03
DK95686 1986-03-03

Publications (4)

Publication Number Publication Date
DK3887D0 DK3887D0 (no) 1987-01-06
DK3887A DK3887A (no) 1987-09-17
DK165692B DK165692B (da) 1993-01-04
DK165692C true DK165692C (da) 1993-11-08

Family

ID=26063196

Family Applications (1)

Application Number Title Priority Date Filing Date
DK003887A DK165692C (da) 1986-01-07 1987-01-06 Phenylbutenderivater, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat indeholdende disse, samt anvendelse af disse til fremstilling af et medikament nyttigt til inhibering af gaba-optagelse i mennesker

Country Status (12)

Country Link
US (1) US4931450A (no)
EP (1) EP0231996B1 (no)
JP (1) JPH0791289B2 (no)
AU (1) AU600248B2 (no)
CA (1) CA1297105C (no)
DE (1) DE3787657T2 (no)
DK (1) DK165692C (no)
ES (1) ES2059360T3 (no)
FI (1) FI89481C (no)
IL (1) IL81179A (no)
NO (1) NO170976C (no)
PT (1) PT84064B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
US5112980A (en) * 1989-12-27 1992-05-12 Monsanto Company Process of preparing substituted pyridine compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
WO1997049403A1 (en) * 1996-06-27 1997-12-31 University College Dublin Use of nipecotic acid or guvacine derivatives for the manufacture of a medicament for the treatment of postischemic neurodegenerative disorders
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
DE19840611A1 (de) * 1998-09-05 2000-03-09 Klaus Wanner GABA-uptake-Inhibitoren mit Pyrrolidinstruktur
ATE327986T1 (de) 2001-02-16 2006-06-15 Allelix Neuroscience Inc Thiophen substituierte amin derivate als glyt-1 inhibitoren
US7189757B2 (en) * 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
WO2003032912A2 (en) * 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
US4681884A (en) * 1983-09-01 1987-07-21 Boehringer Ingelheim Pharmaceuticals, Inc. Diazine-ethenylphenyl oxamic acids and esters and salts thereof

Also Published As

Publication number Publication date
EP0231996B1 (en) 1993-10-06
NO870049D0 (no) 1987-01-06
AU600248B2 (en) 1990-08-09
DE3787657D1 (de) 1993-11-11
PT84064B (pt) 1989-07-31
FI870059A0 (fi) 1987-01-07
US4931450A (en) 1990-06-05
DK165692B (da) 1993-01-04
JPS62228073A (ja) 1987-10-06
FI89481C (fi) 1993-10-11
EP0231996A3 (en) 1988-10-19
FI89481B (fi) 1993-06-30
JPH0791289B2 (ja) 1995-10-04
NO170976C (no) 1993-01-06
IL81179A (en) 1992-02-16
CA1297105C (en) 1992-03-10
PT84064A (en) 1987-02-01
IL81179A0 (en) 1987-08-31
FI870059A (fi) 1987-07-08
NO870049L (no) 1987-07-08
EP0231996A2 (en) 1987-08-12
DK3887D0 (no) 1987-01-06
DE3787657T2 (de) 1994-02-03
NO170976B (no) 1992-09-28
DK3887A (no) 1987-09-17
AU6719387A (en) 1987-07-09
ES2059360T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
DK164868C (da) Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK158587A (da) Thiazepinforbindelser, fremgangsmaader til fremstilling deraf samt farmaceutiske, praeparater, der indeholder disse forbindelser
DK165692C (da) Phenylbutenderivater, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat indeholdende disse, samt anvendelse af disse til fremstilling af et medikament nyttigt til inhibering af gaba-optagelse i mennesker
NO870666L (no) Substituerte thienoinidasolderivater, fremgangsmaate til deres fremstilling og farmasoeytiske tilberedninger inneholdende disse og deres anvendelse som magesyresekresjonshemmer
DK214090A (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
DK219387A (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK349387A (da) Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel
DK170785D0 (da) 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK191086D0 (da) Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK307085A (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK163512C (da) Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne
DK2488D0 (da) Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK273187A (da) Farmaceutiske praeparater indeholdende naphthyridinderivater
DK645988D0 (da) Biphenylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende samme
DK240984D0 (da) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer,fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK106287D0 (da) Glycero-3(2)-phospho-l-serin-derivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK561787A (da) Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel
DK352586D0 (da) 11-methylen-oestr-15-ener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende disse oestrener
DK379287D0 (da) 1,3-propandiaminderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK141784A (da) Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK39388A (da) Isoxazol-derivater, fremgangsmaade til fremstilling heraf samt farmaceutiske praeparater indeholdende saadanne derivater

Legal Events

Date Code Title Description
PBP Patent lapsed